208 related articles for article (PubMed ID: 23116461)
1. Synthesis and characterization of a melanoma-targeted fluorescence imaging probe by conjugation of a melanocortin 1 receptor (MC1R) specific ligand.
Tafreshi NK; Huang X; Moberg VE; Barkey NM; Sondak VK; Tian H; Morse DL; Vagner J
Bioconjug Chem; 2012 Dec; 23(12):2451-9. PubMed ID: 23116461
[TBL] [Abstract][Full Text] [Related]
2. Radiofluorinated rhenium cyclized α-MSH analogues for PET imaging of melanocortin receptor 1.
Ren G; Liu S; Liu H; Miao Z; Cheng Z
Bioconjug Chem; 2010 Dec; 21(12):2355-60. PubMed ID: 21073170
[TBL] [Abstract][Full Text] [Related]
3. 64Cu-labeled alpha-melanocyte-stimulating hormone analog for microPET imaging of melanocortin 1 receptor expression.
Cheng Z; Xiong Z; Subbarayan M; Chen X; Gambhir SS
Bioconjug Chem; 2007; 18(3):765-72. PubMed ID: 17348700
[TBL] [Abstract][Full Text] [Related]
4. In vivo and in silico pharmacokinetics and biodistribution of a melanocortin receptor 1 targeted agent in preclinical models of melanoma.
Tafreshi NK; Silva A; Estrella VC; McCardle TW; Chen T; Jeune-Smith Y; Lloyd MC; Enkemann SA; Smalley KS; Sondak VK; Vagner J; Morse DL
Mol Pharm; 2013 Aug; 10(8):3175-85. PubMed ID: 23763620
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization and optimization of in vitro properties of NIR-fluorescent cyclic α-MSH peptides for melanoma imaging.
von Kiedrowski V; Hübner R; Kail D; Cheng X; Schirrmacher R; Wängler C; Wängler B
J Mater Chem B; 2020 Dec; 8(46):10602-10608. PubMed ID: 33136101
[TBL] [Abstract][Full Text] [Related]
6. Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog.
Cheng Z; Zhang L; Graves E; Xiong Z; Dandekar M; Chen X; Gambhir SS
J Nucl Med; 2007 Jun; 48(6):987-94. PubMed ID: 17504880
[TBL] [Abstract][Full Text] [Related]
7. A gallium-labeled DOTA-alpha-melanocyte- stimulating hormone analog for PET imaging of melanoma metastases.
Froidevaux S; Calame-Christe M; Schuhmacher J; Tanner H; Saffrich R; Henze M; Eberle AN
J Nucl Med; 2004 Jan; 45(1):116-23. PubMed ID: 14734683
[TBL] [Abstract][Full Text] [Related]
8. Homologous regulation of melanocortin-1 receptor (MC1R) expression in melanoma tumor cells in vivo.
Froidevaux S; Eberle AN
J Recept Signal Transduct Res; 2002; 22(1-4):111-21. PubMed ID: 12503610
[TBL] [Abstract][Full Text] [Related]
9. Melanoma Imaging Using
Zhang C; Zhang Z; Lin KS; Lau J; Zeisler J; Colpo N; Perrin DM; Bénard F
Mol Pharm; 2018 Jun; 15(6):2116-2122. PubMed ID: 29714486
[TBL] [Abstract][Full Text] [Related]
10. PET of malignant melanoma using 18F-labeled metallopeptides.
Ren G; Liu Z; Miao Z; Liu H; Subbarayan M; Chin FT; Zhang L; Gambhir SS; Cheng Z
J Nucl Med; 2009 Nov; 50(11):1865-72. PubMed ID: 19837749
[TBL] [Abstract][Full Text] [Related]
11. Preclinical evaluation of melanocortin-1 receptor (MC1-R) specific
Nagy G; Dénes N; Kis A; Szabó JP; Berényi E; Garai I; Bai P; Hajdu I; Szikra D; Trencsényi G
Eur J Pharm Sci; 2017 Aug; 106():336-344. PubMed ID: 28625749
[TBL] [Abstract][Full Text] [Related]
12. Melanocortin 1 Receptor-Targeted α-Particle Therapy for Metastatic Uveal Melanoma.
Tafreshi NK; Tichacek CJ; Pandya DN; Doligalski ML; Budzevich MM; Kil H; Bhatt NB; Kock ND; Messina JL; Ruiz EE; Delva NC; Weaver A; Gibbons WR; Boulware DC; Khushalani NI; El-Haddad G; Triozzi PL; Moros EG; McLaughlin ML; Wadas TJ; Morse DL
J Nucl Med; 2019 Aug; 60(8):1124-1133. PubMed ID: 30733316
[TBL] [Abstract][Full Text] [Related]
13. Enhancing the Efficacy of Melanocortin 1 Receptor-Targeted Radiotherapy by Pharmacologically Upregulating the Receptor in Metastatic Melanoma.
Li M; Liu D; Lee D; Kapoor S; Gibson-Corley KN; Quinn TP; Sagastume EA; Mott SL; Walsh SA; Acevedo MR; Johnson FL; Schultz MK
Mol Pharm; 2019 Sep; 16(9):3904-3915. PubMed ID: 31318566
[TBL] [Abstract][Full Text] [Related]
14. A novel DOTA-alpha-melanocyte-stimulating hormone analog for metastatic melanoma diagnosis.
Froidevaux S; Calame-Christe M; Tanner H; Sumanovski L; Eberle AN
J Nucl Med; 2002 Dec; 43(12):1699-706. PubMed ID: 12468522
[TBL] [Abstract][Full Text] [Related]
15. A novel CXCR4-targeted near-infrared (NIR) fluorescent probe (Peptide R-NIR750) specifically detects CXCR4 expressing tumors.
Santagata S; Portella L; Napolitano M; Greco A; D'Alterio C; Barone MV; Luciano A; Gramanzini M; Auletta L; Arra C; Zannetti A; Scala S
Sci Rep; 2017 May; 7(1):2554. PubMed ID: 28566721
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of novel 99mTc(I)-labeled homobivalent α-melanocyte-stimulating hormone analogs for melanocortin-1 receptor targeting.
Morais M; Raposinho PD; Oliveira MC; Correia JD; Santos I
J Biol Inorg Chem; 2012 Apr; 17(4):491-505. PubMed ID: 22286955
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution and Multicompartment Pharmacokinetic Analysis of a Targeted α Particle Therapy.
Tichacek CJ; Tafreshi NK; Kil H; Engelman RW; Doligalski ML; Budzevich MM; Gage KL; McLaughlin ML; Wadas TJ; Silva A; Moros E; Morse DL
Mol Pharm; 2020 Nov; 17(11):4180-4188. PubMed ID: 32960613
[TBL] [Abstract][Full Text] [Related]
18. Key amino acid residue in Melanocortin-1 receptor (melanocyte α-MSH receptor) for ligand selectivity.
Yang Y; Chen M; Ventro G; Harmon CM
Mol Cell Endocrinol; 2017 Oct; 454():69-76. PubMed ID: 28579117
[TBL] [Abstract][Full Text] [Related]
19. A melanin-independent interaction between Mc1r and Met signaling pathways is required for HGF-dependent melanoma.
Wolnicka-Glubisz A; Strickland FM; Wielgus A; Anver M; Merlino G; De Fabo EC; Noonan FP
Int J Cancer; 2015 Feb; 136(4):752-60. PubMed ID: 24975581
[TBL] [Abstract][Full Text] [Related]
20. Increasing molar activity by HPLC purification improves 68Ga-DOTA-NAPamide tumor accumulation in a B16/F1 melanoma xenograft model.
von Hacht JL; Erdmann S; Niederstadt L; Prasad S; Wagener A; Exner S; Beindorff N; Brenner W; Grötzinger C
PLoS One; 2019; 14(6):e0217883. PubMed ID: 31163066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
